Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Short % of Float

0.05%

Insider Ownership

0.00%

Institutional Own.

2.69%

Qtr Updated

09/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PHAXIAM phages Details
Staph aureus , Prosthetic joint infection

Phase 2

Data readout

PHAXIAM phages Details
Staph aureus , Endocarditis infections

Phase 1

Data readout

Eryaspase (GRASPA) (asparaginase) Details
Pancreatic cancer, Solid tumor/s, Cancer

Failed

Discontinued

Eryaspase (GRASPA) (asparaginase) Details
Leukemia, Acute lymphoblastic leukemia, Cancer

Failed

Discontinued

Failed

Discontinued

Eryaspase (GRASPA) (asparaginase) Details
Breast cancer, Triple-negative breast cancer , Cancer

Failed

Discontinued